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Five patients who developed neutropenia following intravenous administration of high dose
oxacillin for serious Staphylococcus aureus infection are described. Neutropenia was reversible
with cessation of intravenous oxacillin therapy. Two patients were continued on oral oxacillin
without untoward effects.
Although there have been many adverse hematological effects ascribed to the use
of penicillin and some semisynthetic penicillins (methicillin (1, 2) and more recently
nafcillin (3, 4)), we know ofonly one previous report which suggests a casual relation-
ship between neutropenia and oxacillin therapy (5). The reasons for this infrequent
associated effect have not yet been delineated but may partially involve relationships
between the infective agent and host defense, duration of antibiotic use, intravenous
administration, or the structural characteristics ofoxacillin per se and its interaction
with granulocytic bone marrow precursors. The present report describes five
patients seen by us during the last 2 years who received high dose intravenous
oxacillin therapy for Staphylococcus aureus infection and developed neutropenic
leukopenia.
CASE REPORTS
Case 1. (Fig. 1, Table 1). A 13-year-old Negro male was admitted to the Yale-
New Haven Hospital with clinical evidence of septic arthritis of the left hip joint.
Two days prior to admission he noted the onset offever, mild rhinorrhea, and left hip
pain accentuated by motion. There was no history of trauma.On admission to the
hospital the patient had a temperature of 1030 F, a pulse of 120, and respirations of
20/min. On physical examination, the left hip revealed limitation of flexion and ex-
tension to 15° and limitation of internal and external rotation of 60° with con-
comitant pain with movement. Admission laboratory work revealed a white blood
cell count of 16,000/mm3 with 70% segmented neutrophils, 19% band forms, 3%
lymphocytes, and 8% monocytes. The hemoglobin was 13 g/100 ml and the
hematocrit was 36%. The sedimentation rate was 36 mm/hr. Urinalysis was normal.
Films of the left hip were normal. Surgical exploration of the left hip revealed an
inflammatory synovitis. Bacterial cultures ofthe left hip synovium yielded S. aureus
and S. epidermidis, both sensitive to oxacillin. Three sets of blood cultures grew S.
aureus sensitive to oxacillin. Intravenous oxacillin in the dosage of 1 g ever 6 hr was
begun immediately postoperatively. The dose of intravenous oxacillin was increased
to 2 g every 6 hr on the following day. On the 19th day of intravenous oxacillin
therapy (Table 1, Fig. 1) the leukocyte count fell to 4000/mm3 with a differential
count of 40% neutrophils, 19% band forms, 2% eosinophils, 30% lymphocytes, and
7% monocytes. The temperature rose slightly to 380 C. On the 20th day of
351
Copyright © 1976 by Academic Press, Inc.
All rights ofreproduction in any form reserved.AHERN, HICKS AND ANDRIOLE
12 gm IV/24 hr
O///////0xociiiin //////,
20,000 Gronulocytes -00 lo
E
E Total Leukocytes
5,000 750
0 z4
W t0ooO 50~
CD
~5,000 -25
oI
0 5 10 15 20 25 30 35 40
DAY OF THERAPY
FIG. 1. Case report number 1, antibiotic therapy and hematological profile during therapy (see Table 1).
intravenous oxacillin therapy, the leukocyte count was 2000/mm3 with no segmented
neutrophils and 11% band forms. Intravenous oxacillin was discontinued on the 21st
day of therapy. During the next 4 days, the white blood cell count rose to normal
range with a normal differential count. The patient received no other medication dur-
ing his hospital admission. He was discharged on the 23rd hospital day. A leukocyte
count 13 days following cessation of intravenous oxacillin therapy was 8100/mm3
with 59% segmented neutrophils, 15% band forms, 21% lymphocytes, 3% monocytes,
and 1 % eosinophils.
Case 2. (Fig. 2, Table 2). On February 18, 1974, a 54-year-old male was admitted
to Yale-New Haven Hospital with the diagnosis ofosteomyelitis of the lumbosacral
spine. The patient previously had a history of lower back pain and was treated in
another hospital with ampicillin, 500 mg every 6 hr orally for a staphylococcal uri-
nary tract infection. He was on oral ampicillin at the time of admission to the
Yale-New Haven Hospital. Admission white blood count was 5800/mm3 with 68%
segmented neutrophils, 0% bands, 17% lymphocytes, 6% eosinophils, and 9%
monocytes. The sedimentation rate was 32 mm/hr. The urinalysis was normal. The
patient was afebrile. Lumbosacral spine films revealed osteomyelitis of the second
and third lumbar vertebrae. A bone biopsy of the third lumbar vertebrae taken dur-
ing surgical exploration on the sixth day of admission grew S. aureus resistant to
TABLE 1
Patient Number 1
Total Neutrophils (%) leukocyte Netohs(% Lympho- Mono- Eosino-
Days of Antibiotic count Seg- Band cytes cytes phils Others
therapy therapy (per mm3) mented forms (%) (%) (%) (%)
1 Oxacillin,
4g/day iv 16,000 70 19 3 8 0 0
2 Oxacillin,
8 g/day iv - - - - - - -
19 4,000 40 19 30 7 2 2
20 2,000 0 11 74 8 4 3
21 Oxacillin
discontinued - - - - - - -
22 3,900 12 19 51 11 4 3
25 4,600 44 10 26 10 7 3
36 8,100 59 15 21 3 1 1
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FIG. 2. Case report number 2, antibiotic therapy and hematological profile during therapy (seeTable 2).
penicillin and ampicillin and sensitive to oxacillin. The pathological report of the
lumbar bone revealed acute and chronic inflammation with focal necrosis, infiltration
with plasma cells, lymphocytes, monocytes, polymorphonuclear cells, and a few
giant cells. Immediately postoperatively, the patient was begun on intravenous
oxacillin, 2 g every 4 hr in addition to Probenicid, 500 mg orally twice a day.
Intravenous oxacillin was decreased to 10 g/24 hr on the 22nd day oftherapy. On the
26th day of intravenous oxacillin therapy, the leukocyte count fell to 2900/mm3 with
14% segmented neutrophils, 1% bands, 47% lymphocytes, and 17% monocytes with
18% eosinophils (Fig. 2, Table 2). The intravenous oxacillin was discontinued and the
patient was started on therapy with oral dicloxacillin, 500 mg every 6 hr with con-
tinuation of the Probenicid. The white blood cell count returned to normal 8 days
after discontinuing intravenous oxacillin. There was no depression ofthe white blood
cell count over a period of8 months oforal therapy with dicloxacillin. Representative
white blood cell counts and differential cell counts during therapy were: 6900/mm3
with 71% segmented neutrophils, 23% lymphocytes, 4% monocytes, and 2% eosino-
phils at 6 weeks, and 6500/mm3 with 58% segmented neutrophils, 29% lymphocytes,
TABLE 2
Patient Number 2
Total Netohl %
leukocyte Neutrophils(%) Lympho- Mono- Eosino-
Days of Antibiotic count Seg- Band cytes cytes phils Others
therapy therapy (per mm3) mented forms (%) (%) (%) (%)
I Oxacillin,
12 g/day iv 9,400 - - - - - -
7 10,100 84 7 3 5 0 1
10 9,900 77 6 9 6 2 0
18 6,700 64 14 11 6 4 1
22 Oxacillin,
10 g/day iv - - _ - - - -
26 Oxacillin
discontinued
Dicloxacillin
2 g/day po 2,900 14 1 52 11 18 4
34 6,100 67 0 26 2 5 0
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FIG. 3. Case report number 3, antibiotic therapy and hematological profile during therapy (seeTable 3).
TABLE 3
Patient Number 3
Total Neutrophils (%) leukocyte Nurpis() Lympho- Mono- Eosino-
Days of Antibiotic count Seg- Band cytes cytes phils Others
therapy therapy (per mm3) mented forms (%) (%) (%) (%)
A. First febrile episode
1 Oxacillin,
6 g/day iva
2
3
5 1
9,200 82
10,100 77
4,600 74
4,400 71
6 Oxacillin
discontinued 3,000 50
B. Second febrile episode
1 Oxacillin,
12 g/day iv 20,500 73
2 13,700 70
8 14,900 57
11 10,500 66
16 7,200 61
18 5,400 57
23 4,300 37
28 Oxacillin
discontinued 3,400 22
32 Dicloxacillin,
I g q.i.d. po 5,300 4
35 1 5,600 40
39 ,r 9,900 57
49 Dicloxacillin
discontinued 8,800 69
10 7 1 0 0
4 17 2 0 0
1 20 5 0 0
8 18 3 0 0
0 47 2 1 0
21 3 3 0 0
23 1 6 0 0
11 17 9 4 2
13 13 5 1 2
5 29 4 1 0
4 26 9 4 0
3 44 9 7 0
3 44 26 3 2
6 65 21 3 1
12 34 10 1 3
6 25 4 2 6
5 18 5 1 2
C. Third febrile episode, 2 weeks after discontinuation ofdicloxacillin
1 Oxacillin
12 g/day iv - - - -
2 11,000 89 4 6
6 6,500 66 8 16
16 8,100 56 3 34
41 6,500 63 - 25
aGentamicin, 80 mg iv x 1 dose; and ampicillin, 2 g iv x 1 dose.
9 1 0
5 1 1
6 6 0
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11 % monocytes, and 1 % eosinophils at 5 months. Two months after discontinuing
oral oxacillin, the white blood cell count was 6800/mm3 with 66% segmented neutro-
phils, 26% lymphocytes, and 8% monocytes.
Case 3. (Fig. 3, Table 3). A 71-year-old white male was admitted to the West
Haven Veterans Administration Hospital on January 10, 1975. The patient was
confused and unable to give a history of his illness. He had previously been admitted
to a nearby hospital for a seizure presumed secondary to alcoholic withdrawal. On his
January 10, 1975, admission to the West Haven Veterans Administration Hospital,
the temperature was 103°F, the blood pressure was 125/80 mm Hg, respirations
were 20/min, and the pulse was 100. On physical examination, there were a few rales
in the left lower lobe posteriorly. The patient's left pupil was greater in size than the
right pupil, but both were reactive to light. There was a question of mild left facial
weakness.
Laboratory data on admission to the hospital revealed a total white blood cell
count of 9200/mm3 with 82% segmented neutrophils, 10% bands, 7% lymphocytes,
and 1% monocytes. The sedimentation rate was 42 mm/hr. A culture of the urine
grew more than 10,000 cocci. The cerebrospinal fluid was clear and analysis revealed
a glucose content of 77 mg%, and a protein content of 45 mg%, and contained no
cells. Gram stain and culture were negative. The sputum grew 2+ S. epidermidis.
Blood cultures were negative. A film of the chest revealed atelectasis or infiltrate in
the left lower lobe.
Course in the hospital: The patient experienced three febrile episodes while in the
hospital. The first febrile episode (Table 3A) was on admission when the patient had a
temperature of 1030 F. The patient was empirically started on intravenous oxacillin in
the dose of 1 g every 4 hr and was also given one 80 mg dose of gentamicin
intravenously and one 2-g dose of ampicillin intravenously for possible sepsis. On the
sixth day of therapy, the white blood cell count dropped to 3300/mm3 with 50% seg-
mented neutrophils, 47% lymphocytes, 2% monocytes, and 1% eosinophils.
Intravenous oxacillin was discontinued. Five days after discontinuing the intravenous
oxacillin, the leukocyte count rose to 6000/mm3 with 69% segmented neutrophils, 2%
band forms, 28% lymphocytes,and 1% eosinophils. Nine days after cessation of the
oxacillin therapy, the temperature rose to 103° F, and the patient was begun on a
course of oral ampicillin therapy. The following day a temperature of 105°F was
recorded. A grade III/VI systolic murmur was heard at the apex of the heart and
radiated into the axilla. At that time, the white blood cell count was 25,000/mm3 with
73% segmented neutrophils, 21% band forms, 3% lymphocytes, and 3% monocytes
(Table 3, Fig. 3). The erythrocyte sedimentation rate was 62 mm/hr. Intravenous
oxacillin at a dose of 2 g every 4 hr was reinstituted. Six sets ofblood cultures drawn
during the second febrile episode and prior to the initiation ofoxacillin therapy grew
S. aureus, coagulase positive. On the 23rd day of intravenous oxacillin therapy, the
white blood cell count had fallen to 4300/mm3 with 37% segmented neutrophils, 3%
band forms, 44% lymphocytes, 9% monocytes, and 7% eosinophils. On the 28th day
of therapy, the white blood cell count was 3400/mm3 with 22% segmented neutro-
phils, 3% band forms, 44% lymphocytes, 26% monocytes, and 2% eosinophils.
Intravenous oxacillin therapy was discontinued and oral dicloxacillin, 250 mg four
times daily, was initiated. Four days later the white blood cell count was 5300/mm3
with 4% segmented neutrophils, 6% band forms, 65% lymphocytes, 21% monocytes,
and 3% eosinophils. By the seventh day of oral therapy, the white blood cell count
and differential had returned to normal (i.e., 5600/mm3 with 40% segmented neutro-
phils, 12% band forms, 34% lymphocytes, 10% monocytes, and 1% eosinophils). Oral
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FIG. 4. Case report number 4, antibiotic therapy and hematological profile during therapy (seeTable 4).
dicloxacillin was discontinued after 20 days of therapy. Fourteen days later the
patient's temperature again rose to 1030 F and the white blood cell count was 20,-
000/mm3 with 65% segmented neutophils, 18% band forms, 16% monocytes, and 1%
eosinophils. Blood cultures were again positive for S. aureus, and intravenous
oxacillin, 2 g every 4 hr, was reinstituted. The patient was treated intravenously for
41 days without the development ofneutropenia and leukopenia.
Case 4. (Fig. 4, Table4). A 24-year-oldjuvenile-onset diabetic was admitted to the
Yale-New Haven Medical Service on August 18, 1974, with complaints ofpersistent
ketonuria, fever, and left flank pain of 3 days duration. The patient's diabetes
mellitus was no longer controlled with his usual insulin dose. Initial physical examina-
tion revealed a temperature of 101°F rectally and mild left costrovertebral angle
tenderness. Initial urinalysis contained 25-30 white blood cells per high powered field
TABLE 4
Patient Number 4
Total Netohl % leukocyt Neutrophils (%) Lympho- Mono- Eosino-
Days of Antibiotic count Seg- Band cytes cytes phils Others
therapy therapy (per mm3) mented forms (%) (%) (%) (%)
I Oxacillin,
12g/day iv 6000 72 13 4 10 1 0
6 8700 61 12 15 6 5 0
10 7900 82 4 10 3 0 1
14 5100 52 3 35 6 2 2
28 2700 26 5 41 8 17 3
29 Oxacillin
discontinued
Clindamycin,
2.7 g/day po 3000 14 2 52 22 3 7
30 3800 28 18 24 22 6 2
33 3900 25 20 27 22 6 0
1 week after 4
cessation
oftherapy None 6800 46 1 36 14 3 0
6 weeks post-
cessation
oftherapy None 7600 73 7 15 5 0 0
Clindamycin therapy was continued after discharge from the hospital for a total courseof 10 days.
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and was 1+ positive for protein and 4+ positive forglucose and ketones. Initial white
blood cell count was 14,900/mm3 with 69% segmented neutrophils, 18% band forms,
8% lymphocytes, and 3% monocytes. He was begun empirically on ampicillin, 1 g
intravenously every 6 hr, and cephalothin, 1 gintravenously every 4 hr. Cultureofthe
admission urine grew coagulase-positive S. aureus. Multiple blood cultures were
negative. The erythrocyte sedimentation rate obtained 10 days after admission was
50 mm/hr. When results of the urine culture were available on August 21, 1974, the
antibiotic coverage was changed to oxacillin, 2 g intravenously every 4 hr, because
the organism was resistant to ampicillin. His subsequent hospital course included
development of a left pleural effusion noted on physical examination and chest film
on August 20, 1975, associated with splinting of the left hemithorax. This physical
finding, in association with persistence of his fever, led to an extensive urological
evaluation which included an intravenous pyelogram, ultrasound of the left kidney,
and renal arteriography, the results of which led to a diagnosis of a left perinephric
abscess. On the 28th day of intravenous oxacillin therapy (September 18, 1974) the
white blood cell count was noted to be2700/mm3 with a differential count of26% seg-
mented neutrophils, 5% band forms, 41% lymphocytes, 8% monocytes, 17% eosino-
phils and 3% atyprical lymphocytes; the erythrocyte sedimentation rate was 21
mm/hr. Intravenous oxacillin was discontinued and clindamycin, 300 mg every 8 hr
orally, was instituted and continued for 10 days, during which time theleukocyte cell
count and differential count improved rapidly. His white blood cell count 1 week after
cessation of all therapy was 6800/mm3 with 46% segmented neutrophils, 1% band
forms, 36% lymphocytes, 14% monocytes, 3% eosinophils, and 1% atypical
lymphocyte. Follow-up renal arteriography approximately 3 months after diagnosis
of the perinephric abscess and 6 weeks after cessation of therapy showed only
minimal narrowing ofthe vessels in the area ofprevious infection.
Case 5 (Fig. 5, Table 5). A 9-month-old infant was admitted to the Yale-New
Haven Hospital Pediatric Service on August 27, 1975, with a 2-day history offever,
vomiting, irritability, and limitation ofmovement ofthe left leg. He had been seen by
a physician 2 days prior to admission and was begun on oral penicillin for the fever.
The symptoms had not improved and the child was admitted to the pediatric ward
when the mother noted warmth over the left knee and brought him to the Emergency
Room. Positive physical findings at that time were limited to a temperature of 1020
F., a pulse of 100, and a tender, warm, erythematous, left knee with evidence of
effusion and limitation of flexion. His white blood cell count was 13,300/mm3 with
35% segmented neutrophils, 51% lymphocytes, 12% monocytes, and 1% eosinophils.
The erythrocyte sedimentation rate was 59 mm/hr. Aspiration of the left kneejoint
yielded 6 ml ofpurulent fluid. The protein content was 5.7 g%. Total nucleated cells
were 89,000/mm3, 95% of which were neutrophils. Gram stain of the material
revealed sheets of neutrophils and a few gram-positive cocci. No organisms grew on
culture. Blood and cerebrospinal fluid cultures were negative. Films of the left hip
and knee were normal. Surgical exploration of knee joint, on the day of admission,
revealed no communication with the metaphysis of the femur. Oxacillin, 350 mg
every 4 hr, and ampicillin, 350 mg every 4 hr, was begun intravenously on the day of
admission (August 27, 1975). He became afebrile on the fourth hospital day. On Sep-
tember 16, 1975, after 14 days of antibiotic therapy with both agents, it was noted
that his white blood cell count had fallen to 5,600/mm3 with a differential of 1% seg-
mented neutrophils, 1% band forms, 88% lymphocytes, 5% monocytes, and 2%
eosinophils. The sedimentation rate had fallen to 42 mm/hr. Oxacillin was dis-
continued on September 17 and cephalothin substituted, 80 mg intravenously every 4
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FIG. 5. Case report number 5, antibiotic therapy and hematological profile during therapy (seeTable 5).
hr. Five days later the white blood cell count had returned to 13,300/mm3, with a
differential count of 18% neutrophils, 1% band forms, 67% lymphocytes, 11%
monocytes, and 3% eosinophils. All antibiotics were discontinued on September 23,
1975, after 25 days of therapy. A white blood cell count one week later was
9400/mm3, 24% neutrophils, 58% lymphocytes, 8% monocytes, and 2% eosinophils.
The erythrocyte sedimentation rate was 30 mm/hr.
TABLE 5
Patient Number 5
Total Netohl %
leukocyte Neutrophils(%) Lympho- Mono- Eosino-
Days of Antibiotic count Seg- Band cytes cytes phils Others
therapy therapy (per mm3) mented forms (%) (%) (%) (%)
I Oxacillin,
6g/day iv
Ampicillin,
2 g/day iv 13,300 35 0 51 12 1 1
5 Oxacillin,
2.1 g/day iv
Ampicillin,
2.1 g/day iv 11,200 38 0 56 6 0 0
7 14,200 21 0 60 13 5 1
13 7,300 28 2 57 6 4 3
20 5,600 1 1 88 5 2 3
21 Ampicillin,
2.1 g/day iv
Cephalothin,
480 mg/day iv
Oxacillin
discontinued 7,100 4 0 85 10 1 0
22 7,700 2 0 90 7 0 1
24 8,100 7 0 80 8 5 0
26 13,300 18 1 67 11 3 0
27 All antibiotics
discontinued
30 None 11,800 20 0 65 7 7 1
34 None 9,400 24 0 58 8 2 8OXACILLIN-INDUCED NEUTROPENIA
DISCUSSION
Reversible adverse hematological reactions following the administration of the
semisynthetic penicillins, nafcillin and methicillin, for the treatment of ,B-lactamase-
producing staphylococcal infections have been infrequently reported (1-4, 6). Bone
marrow examination in two recent studies involving nafcillin therapy demonstrated a
maturation arrest of the myeloid series at the myelocyte stage without depression of
the megakaryocytic or erythroid series (3, 4). Our review of the literature has
revealed only one case of apparent oxacillin-induced neutropenia and leukopenia
associated with eosinophilia (5). In that case report, the antibiotic was oral sodium
oxacillin (5-methyl-3-phenyl-4-isoxazolyl penicillin). However, the patient had pre-
viously demonstrated clear evidence of penicillin hypersensitivity with angioneurotic
edema, while receiving penicillin and eosinophilia and pruritus during methicillin
therapy. Bone marrow aspirate obtained after cessation of oxacillin therapy for
persistent neutropenia revealed a maturation arrest of the myeloid series with rela-
tive hypoplasia of the erythroid series. One week after discontinuation of the
oxacillin, prednisone therapy was initiated since there had been no evidence of spon-
taneous bone marrow recovery. After 3 days of steroid therapy, the total leukocyte
counts and differential counts had returned to normal values. This author also
reported evidence ofhepatocellular damage, in that the serum transaminase and uri-
nary urobilinogen levels rose in this patient during oxacillin therapy and spon-
taneously improved with cessation ofthe drug prior to the institution ofprednisone, a
finding also noted by Huang et al, in children with cystic fibrosis (6). No clinical or
laboratory evidence of liver involvement was found in four of our patients. Patient
number 3 developed abnormal liver function tests after admission with a markedly
increased alkaline phosphatase and mild transaminase (SGOT) and lactic dehydro-
genase elevations. The values returned to normal while on oxacillin therapy. The
etiology of the abnormalities was unknown but a biliary stone was implicated. Con-
sequently, we have no evidence ofoxacillin-related hepatotoxicity in our patients.
In our series of five patients receiving intravenous oxacillin therapy, three
demonstrated a leukopenia and all five developed a transient neutropenia. All ofour
patients had received at least 2 weeks ofintravenous therapy prior to theobservation
of the peripheral white blood cell dyscrasias. Cessation of intravenous therapy alone
brought prompt recovery of the peripheral leukocyte and differential cell counts
within 1 week. In our experience, we have seen many patients with similar degrees of
osteomyelitis on oxacillin therapy who did not develop leukopenia. Therefore, this
leukocyte dyscrasia is not felt to be related to the infection per se. Similar reversion
ofneutropenia towards normal has been observed to occur within 72 hr following dis-
continuation of methicillin (8). Institution of oral dicloxacillin in two of our patients
did not impede the return ofthe peripheral white blood cell count to normal values.
An eosinophilia reaction has previously been described with oxacillin (9). Eosino-
philia in the range of 18% occurred in two ofour five patients, and a range of4 to 7%
was seen in the remaining patients. The eosinophils regressed with cessation of
intravenous therapy. No other systemic manifestations ofdrug hypersensitivity were
noted in our patients. Erythrocyte sedimentation rates were elevated in all five
patients at the time of admission. These values continued to improve during the time
of the neutropenic leukopenia. Four ofthe five patients remained afebrile during this
time period. Patient number 3 developed a severe left arm phlebitis at his intravenous
infusion site and was febrile to 1020 F during the neutropenia. He defervesced within
24 hr, with the changing of the intravenous site and the application of warm soaks.
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Furthermore, while all the patients presented with an anemia ofvarying severity, this
hematological abnormality improved spontaneously in three of the patients (1, 2, 4).
Patient number 3 was evaluated for his anemia 2 weeks after admission and was
found to have both folate deficiency and an anemia compatible with chronic disease
with a bone marrow showing abundant iron stores. He received 2 units ofpacked red
blood cells which increased the hematocrit to 27%, a value which he maintained
throughout the remainder of his hospital course. Patient number 5, the infant, was
found to be iron deficient and responded rapidly to oral iron therapy with a brisk
reticulocytosis which persisted throughout theperiod ofleukopenia.
The mechanism of the selective bone marrow suppression by the semisynthetic
penicillins is as yet undefined. A direct toxic effect on the white blood cell precursors
is suggested by the improvement occurring merely with cessation of antibiotic
administration. The associated eosinophilia seen in two ofour patients and observed
by others in association with drug allergy, i.e., fever (3) and rash (4) and prior reac-
tions to penicillin (4), suggests a hypersensitivity reaction to oxacillin leading to a
marrow arrest. However, further studies are needed to support this hypothesis.
Transient neutropenia and leukopenia appear to be complications of high dose
intravenous oxacillin therapy in certain patients and warrant clinical alertness and
monitoring of the hematological profile of patients when this antibiotic is employed.
Continued oral therapy with dicloxacillin [3 (2, 6-dichlorphenyl)-5-methyl-4-
isoxazolyl penicillin], ranging from 1 week to 8 months in two ofour patients, did not
perpetuate the hematological abnormalities noted during high dose intravenous
oxacillin therapy. Thus, oral dicloxacillin may be a suitable alternative should these
side effects beobserved and should intravenous therapy no longer be required.
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